Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats

This publication has 25 references indexed in Scilit:

• Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex
  General Pharmacology: The Vascular System, 1986
• The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour
  European Journal of Pharmacology, 1983
• Pharmacological evidence against the involvement of the D1 subtype of dopamine receptors in apomorphine-induced hypothermia
  Neuroscience Letters, 1983
• ?-Methyl-p-tyrosine inhibition of a conditioned avoidance response: Reversal by dopamine applied to the nucleus accumbens
  Psychopharmacology, 1982
• Increase in rat striatal acetylcholine content by bromocriptine: Evidence for an indirect dopaminergic action
  Life Sciences, 1981
• Stereospecific Antagonism by d-Butaclamol of Dopamine-Induced Relaxation of the Isolated Rabbit Mesenteric Artery
  Journal of Cardiovascular Pharmacology, 1981
• Responses of central neurones to piribedil and 2-bromo-α-ergocryptine: Comparison with dopamine and apomorphine
  European Journal of Pharmacology, 1978
• Bromocriptine is a potent α-adrenoceptor antagonist in the perfused mesenteric blood vessels of the rat
  Journal of Pharmacy and Pharmacology, 1978
• Interaction of Ergot Drugs with Central Monoamine Systems
  Pharmacology, 1978
• Dopamine and noradrenaline receptor stimulation: Reversal of reserpine-induced suppression of motor activity
  Psychopharmacology, 1973